Diabetes mellitus

9 trials 5 recruiting MedDRA PT
9 Registered trials
5 Recruiting
8 Unique sponsors
10 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
A Gastroenterology (ATC A) 3
M Musculoskeletal (ATC M) 1
G Urology/Gynaecology (ATC G) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 6 substances
SGLT2 inhibitor 3 substances
GLP-1 receptor agonist 1 substance
Phase III: 2 Phase II/III: 1 Phase II: 1 Phase I/II: 1 Phase IV: 2 Phase I (Other): 1 Phase I (First in Human): 1

Filter these 9 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 9 trials

Phase III

2 trials
  • Humanitas Mirasole S.p.A. Academic
    CANAGLIFLOZIN; DAPAGLIFLOZIN; EMPAGLIFLOZIN
    2025-523375-29-00 1 country n=300
    Pending
  • Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu Academic
    ALLOPURINOL
    2024-517610-15-00 1 country 2024 n=1,116
    Recruiting

Phase II/III

1 trial
  • Vertex Pharmaceuticals Inc. Commercial
    ZIMISLECEL
    2024-513929-23-00 5 countries 2023 n=8
    Recruiting

Phase II

1 trial
  • Karolinska University Hospital Academic
    EMPAGLIFLOZIN; PIOGLITAZONE; SEMAGLUTIDE
    2024-513416-98-00 2 countries 2023 n=90
    Recruiting

Phase I/II

1 trial
  • Academisch Ziekenhuis Leiden Academic
    IMP not specified
    2023-508558-25-01 1 country 2024 n=10
    Recruiting

Phase IV

2 trials
  • Amsterdam UMC Stichting Academic
    ESTRADIOL; PROGESTERONE, MICRONISED
    2025-523214-83-00 1 country 2026 n=48
    Recruiting
  • Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic
    SEMAGLUTIDE
    2025-523977-40-00 1 country n=90
    Pending

Phase I (Other)

1 trial

Phase I (First in Human)

1 trial
  • Vertex Pharmaceuticals Inc. Commercial
    VX-264
    2024-515583-32-00 3 countries 2023 n=4
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Vertex Pharmaceuticals Inc. Commercial 2 Phase II/III, Phase I (First in Human) 1
Pfizer Inc. Commercial 1 Phase I (Other) 0
Karolinska University Hospital Academic 1 Phase II 1
Humanitas Mirasole S.p.A. Academic 1 Phase III 0
Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu Academic 1 Phase III 1
Amsterdam UMC Stichting Academic 1 Phase IV 1
Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic 1 Phase IV 0
Academisch Ziekenhuis Leiden Academic 1 Phase I/II 1
New trials by year
2023
3
2024
2
2026
1
← All indication landscapes